“Femoflor” is the test for women, “Androflor” – for men Bacteria causing vaginal or urogenital discomfort can be detected with just one test. For women, this test is Femoflor, and for men, Androflor. Femoflor® is a modern PCR-based test and the only diagnostic method that allows complex analysis and evaluation of the vaginal microflora, diagnosis of dysbiosis conditions and detection of sexually transmitted infections. For the first time, with just one study, it is possible to determine the microbial vaginal composition in relation to all microorganisms inhabiting the female vaginal tract. Femoflor is the only test that gives a complete picture of the vaginal bacterial composition, distinguishing normal from disease. Vaginal dysbacteriosis is the most widespread infection in women of reproductive age, and the disease is associated with infertility, induction of spontaneous abortions and problematic pregnancies. 84% of women have no symptoms, and 40% remain misdiagnosed due to deficiencies in widely used diagnostic methods. At the same time, every year one in three women develops vaginal dysbacteriosis. Femoflor® outperforms by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the evaluation of bacterial vaginosis. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner. “Genika” is the only laboratory in Bulgaria that offers these tests. Vaginal dysbiosis is a clinical syndrome with a polymicrobial etiology, resulting from the complex relationships and dynamics between microorganisms that are part of the natural vaginal microflora. The complex assessment of the microbial composition in the female reproductive tract is of the greatest importance for establishing the etiology of the inflammatory process and choosing the appropriate treatment. 84% of women have no symptoms, which is why the condition often goes unnoticed. 40% remain misdiagnosed due to shortcomings of widely used diagnostic methods. Changes in the normal female microbiota increase the risks of developing sexually transmitted infections and lead to negative consequences for women’s health and reproductive functions. About the Femoflor® test Femoflor® is a modern Real-Time PCR based test, allowing complex analysis and assessment of the vaginal microflora, diagnosis of dysbiosis conditions and detection of sexually transmitted infections.Aerobic and anaerobic conditionally pathogenic microorganisms are present in certain concentrations as a component of the natural microflora in the female urogenital tract. Determining the amount of these opportunistic microorganisms and their exact ratio to the number of lactobacilli and the total number of microorganisms gives information about the cervico-vaginal status of the patient, defining a norm or a disease. The traditional, widely used, diagnostic methods are associated with subjectivity in reporting the results and in distinguishing normal from dysbiosis, as well as with the impossibility of cultivating a large number of anaerobic microorganisms with a clear etiology in the development of dysbiosis conditions. This is often the reason for incorrect diagnosis and the appointment of an inappropriate method of treatment, an increase in recurrent cases and the resulting complications. With Femoflor®, for the first time, with just one test, it is possible to establish the entire microbial composition and the relationships between microorganisms in the female urogenital tract and to accurately define the patient’s condition – norm or dysbacteriosis. Approximately 84% of women with vaginal dysbiosis have no symptoms Regular prophylaxis prevents the occurrence of gynecological complications Femoflor® surpasses by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the assessment of bacterial vaginosis. With Femoflor®, the entire microbial composition and relationships between microorganisms in the female urogenital tract can be established. All you have to do is contact your gynecologist and ask about “Femoflor”! Why choose Femoflor® or Androflor®? Femoflor® is a fast, painless and modern molecular diagnostic test for the complex analysis and evaluation of the microflora in the female urogenital tract, for the diagnosis of dysbiosis conditions and for the detection of sexually transmitted infections. The analysis has a great informative value and supports the correct diagnosis and treatment, as well as the monitoring of the condition in the course of treatment. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.by defining a norm or disease. Traditional, widely used, diagnostic methods are associated with subjectivity in reporting the results and distinguishing normal from dysbacteriosis, as well as with the inability to culture a large number of anaerobic microorganisms with a clear etiology in the development of dysbiosis conditions. This is often the reason for incorrect diagnosis and the appointment of an inappropriate method of treatment, an increase in recurrent cases and the resulting complications. With Femoflor®, for the first time, with just one test, it is possible to establish the entire microbial composition and the relationships between microorganisms in the female urogenital tract and to accurately define the patient’s condition – norm or dysbacteriosis. Approximately 84% of women with vaginal dysbiosis have no symptoms Regular prophylaxis prevents the occurrence of gynecological complications Femoflor® surpasses by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the assessment of bacterial vaginosis. With Femoflor®, the entire microbial composition and relationships between microorganisms in the female urogenital tract can be established. All you have to do is contact your gynecologist and ask about “Femoflor”! Why choose Femoflor® or Androflor®? Femoflor® is a fast, painless and modern molecular diagnostic test for the complex analysis and evaluation of the microflora in the female urogenital tract, for the diagnosis of dysbiosis conditions and for the detection of sexually transmitted infections. The analysis has a great informative value and supports the correct diagnosis and treatment, as well as the monitoring of the condition in the course of treatment. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.by defining a norm or disease. The traditional, widely used, diagnostic methods are associated with subjectivity in reporting the results and in distinguishing normal from dysbiosis, as well as with the impossibility of cultivating a large number of anaerobic microorganisms with a clear etiology in the development of dysbiosis conditions. This is often the reason for incorrect diagnosis and the appointment of an inappropriate method of treatment, an increase in recurrent cases and the resulting complications. With Femoflor®, for the first time, with just one test, it is possible to establish the entire microbial composition and the relationships between microorganisms in the female urogenital tract and to accurately define the patient’s condition – norm or dysbacteriosis. Approximately 84% of women with vaginal dysbiosis have no symptoms Regular prophylaxis prevents the occurrence of gynecological complications Femoflor® surpasses by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the assessment of bacterial vaginosis. With Femoflor®, the entire microbial composition and relationships between microorganisms in the female urogenital tract can be established. All you have to do is contact your gynecologist and ask about “Femoflor”! Why choose Femoflor® or Androflor®? Femoflor® is a fast, painless and modern molecular diagnostic test for complex analysis and assessment of the microflora in the female urogenital tract, for the diagnosis of dysbiosis conditions and for the detection of sexually transmitted infections. The analysis has a great informative value and supports the correct diagnosis and treatment, as well as the monitoring of the condition in the course of treatment. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.With Femoflor®, for the first time, with just one test, it is possible to establish the entire microbial composition and the relationships between microorganisms in the female urogenital tract and to accurately define the patient’s condition – norm or dysbacteriosis. Approximately 84% of women with vaginal dysbiosis have no symptoms Regular prophylaxis prevents the occurrence of gynecological complications Femoflor® surpasses by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the assessment of bacterial vaginosis. With Femoflor®, the entire microbial composition and relationships between microorganisms in the female urogenital tract can be established. All you have to do is contact your gynecologist and ask about “Femoflor”! Why choose Femoflor® or Androflor®? Femoflor® is a fast, painless and modern molecular diagnostic test for the complex analysis and evaluation of the microflora in the female urogenital tract, for the diagnosis of dysbiosis conditions and for the detection of sexually transmitted infections. The analysis has a great informative value and supports the correct diagnosis and treatment, as well as the monitoring of the condition in the course of treatment. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.With Femoflor®, for the first time, with just one test, it is possible to establish the entire microbial composition and the relationships between microorganisms in the female urogenital tract and to accurately define the patient’s condition – norm or dysbacteriosis. Approximately 84% of women with vaginal dysbiosis have no symptoms Regular prophylaxis prevents the occurrence of gynecological complications Femoflor® surpasses by 40% the diagnostic specificity and sensitivity of conventional diagnostic tests for the assessment of bacterial vaginosis. With Femoflor®, the entire microbial composition and relationships between microorganisms in the female urogenital tract can be established. All you have to do is contact your gynecologist and ask about “Femoflor”! Why choose Femoflor® or Androflor®? Femoflor® is a fast, painless and modern molecular diagnostic test for complex analysis and assessment of the microflora in the female urogenital tract, for the diagnosis of dysbiosis conditions and for the detection of sexually transmitted infections. The analysis has a great informative value and supports the correct diagnosis and treatment, as well as the monitoring of the condition in the course of treatment. Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.Androflor® is the only complex test for determining the clinically significant concentration of all microorganisms inhabiting the male urogenital tract. Infections in the male urogenital tract are a global problem and are of increasing social and economic importance. Urogenital infections are the most common cause of reproductive disorders in men and a major factor in the development of sterility. Acute and chronic infections damage the germinal epithelium of the testes, disrupt spermatogenesis and deteriorate the quality of seminal fluid. The lack of symptoms is the reason why infections remain unnoticed and are transmitted to the sexual partner.